It can be seen clearly that the few remaining CD34+ CML-CP cells could not divide to form colonies after combination treatment and so had been severely functionally compromised (Figure 3D). The gene discussed is CP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.